Drug Profile
PTL 2015
Alternative Names: Oral dissolving technology - Pacific Therapeutics; PTL-2015Latest Information Update: 28 Jul 2018
Price :
$50
*
At a glance
- Originator Pacific Therapeutics
- Class Erectile dysfunction therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Erectile dysfunction
Most Recent Events
- 28 Jul 2018 No recent reports of development identified for clinical-Phase-Unknown development in Erectile-dysfunction in Canada (Sublingual, Tablet)
- 06 Nov 2014 Clinical trials in Erectile dysfunction in Canada (Sublingual)